See Mymee Featured In...
Personalized Trial & Care Helps Autoimmune Disease Patients Reverse Flares, New Research Shows
Autoimmune drugs comprise 54% of specialty pharmaceutical growth but >65% of rheumatic patients have inadequate response to autoimmune Rx in the real world. Peer-reviewed research, published in RMD Open, shows how personalized trials are transforming care for non-responders.
Read More >
The Long and Winding COVID Road
Podcast host Matthew Zachary speaks with Dr. David Putrino, Director Of Rehabilitation Innovation at Icahn School of Medicine at Mount Sinai and returning guest, Mette Dyhrberg, Founder & CEO of Mymee, for a deep dive conversation on the continuing mystery of Long COVID.
Read More >
Patient-Reported Outcomes Become More Involved in Treating, Managing Rheumatic Diseases in 2022
With a great deal of marginalized patients navigating burdensome, chronic, heterogenetic disease today, evaluating a patient’s self-evidence is helping rheumatologists develop treatment plans that address individual needs and goals.
Read More >
Self-reporting platform may improve quality of life in long COVID, autoimmune diseases
Findings from a retrospective, real-world study using Mymee’s self-evidence platform show statistically significant symptom improvements in patients with lupus, RA, long COVID and other autoimmune diseases.
Read More >
What to do When Standard Elimination Diets Fail Autoimmune Patients
In this podcast interview, Mymee’s CEO and Medical Director address questions about the overlap between long COVID and autoimmune symptoms, the alarming rise of ANA positivity and why standard diets are not a panacea.
Read More >
Self-Advocacy Platform Allows Patients with Autoimmune Diseases to Discover Triggers, Improve Disease Management
CEO and founder Mette Dyhrberg shares how her personal autoimmune journey since age 14 sparked her vision for Mymee in this Q&A about how the company’s personalized trial and care platform is helping others finally gain control of symptoms.
Read More >
Self-Evidence: When Treatment Based on the Experience of Others is not Enough
In her oped for Rheumatology Network, our Medical Director discusses the critical role of self-evidence generated through personalized trials to help patients gain control of symptoms, when standard of care fails.
Read More >
My Experience Tracking Flare Triggers
Read how working with Mymee helped this mother of three regain control of her health after being diagnosed with RA, lupus, and other autoimmune conditions.
Read More >
'We Must Do Better': Celeb Cases Highlight Autoimmunity Epidemic
Dr. Nicole Bundy explains why autoimmunity is the silent epidemic we’re not talking about enough.
Read More >
Mymee Named to NYC Digital Health 100 by NYCHBL
NYCHBL recognizes Mymee as one of the most exciting and innovative health startups in New York and a women’s health company to watch.
Read More >
Best Digital Health Product – Galien Foundation
Mymee is nominated as best digital health product by the prestigious Galien Foundation, bringing together innovators and stakeholders to improve the state of human health.
Read More >
COVID-19 and Autoimmunity Link: Help with Long-Haul COVID?
Learn how experts at Mymee’s COVID Summit believe providers can offer care and support to patients on the path to recovery from long COVID symptoms.
Read More >
Older Adults Face Mobility Issues After COVID-19
Read how even mild cases of COVID-19 can have a long-term effect on movement and function in older adults.
Read More >
Searching for Clues and COVID Long Haul Relief
A man in his forties turns to Mymee for help managing his symptoms with long COVID and improving his quality of life.
Read More >
Long COVID in Kids: The New Mono?
Up to 15% of infected youths could develop long COVID after being infected and presumably recovering from the virus. Our Head of Coaching weighs in.
Read More >
FDA on JAK Inhibitors: Lifestyle Interventions in AID Treatment
Dr. Nicole Bundy shares why looking at lifestyle and diet factors is such a vital part of safely treating and supporting patients with autoimmune diseases.
Read More >
Serimmune and Mymee Research Study: Role of Antibodies in SARS-CoV-2 Symptoms
Read about Mymee’s research partnership with Serimmune to understand the presence of antibodies in people with autoimmunity, including disease activity and those most at risk.
Read More >
Joy Fennell on Healing Rheumatoid Arthritis Naturally
See how guided coaching from her Mymee coach helped Joy return to work after learning to manage her RA symptoms.
Read More >
RCT Demonstrates Improved QoL in Lupus Patients Using Mymee Digital Health Program
Results from Mymee’s randomized controlled trial in patients with lupus is published in the Journal of Medical Internet Research.
Read More >
RCT Trial: Health-Related QoL Improvements in Systemic Lupus
See how self-tracking and telehealth coaching with Mymee enabled patients with lupus to find and remove their symptom triggers and achieve statistically significant, clinically meaningful improvements in HRQoL when added to usual care.
Read More >
Mette Dyhrberg on Healing Autoimmune Disease
Listen to Mette Dyhrberg, the founder of Mymee, discuss her personal journey with autoimmunity and how Mymee is helping people with autoimmune diseases and long COVID feel better again.
Read More >
Fast Company Honors Mymee with a World Changing Ideas Award
Fast Company recognizes Mymee’s work helping people with autoimmune-based disorders like lupus, RA, MS, Hashimoto’s and long COVID to regain control of their lives.
Read More >
An Experimental Approach to Pain Management
Enrolling in the Mymee program through her insurance company gave Maddie the chance to listen to her body, pinpoint her triggers, and heal herself holistically.
Read More >
Mette Dyhrberg on the Cure for the Common Co. podcast
Steve Blumenfield, Head of Partnerships & Alliances in WTW’s Innovation group, interviews Mette Dyhrberg about the challenges she faced when she was no longer able to control her autoimmune disease flares with the best of modern medicine and how that led to Mymee's personalized trial and care platform.
Read More >
ACR Patient Perspective: Tonya Hinton-Green
Lupus patient advocate and Mymee client Tonya Hinton-Green shared how becoming engaged in her care with specialized tools and support from Mymee helped her find her personal triggers and gain control of her symptoms in this abstract for ACR Convergence.
Read More >